Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Low-dose Arginine-vasopressin Supplementation on Post-transplant Acute Kidney Injury After Liver Transplantation
NCT06344442Phase 3Recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Apr 2025
- Primary completion
- May 2025
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of vasopressin in acute kidney injury (AKI), sponsored by Assistance publique - Hôpitaux de Paris. Started Apr 2025; status: recruiting.
02
Drugs
vasopressin
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT06344442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06344442.